Loading quotes...

Forecast

The analysts' average price target is €23.78 (-13.21%). The median is €25.03 (-8.65%).

Buy
  13
Hold
  18
Sell
  2

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, MEDNAX had revenue of €442.64M and net profit of €41.49M
(EUR) September 2026
YoY
Revenue 442.64M 5.39%
Gross profit 123.84M 3.55%
Net profit 41.49M 32.11%
EBITDA 70.06M 14.69%

Fundamentals

Metric Value
Market capitalization
€2.08B
Number of shares
78.12M
52-week high/low
€27.31 - €15.41
Dividends No
Beta
0.61
P/E ratio
15.95
PEG ratio
-15.07
P/B ratio
2.71
P/S ratio
1.19

Company profile

MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was founded in 1979 and is based in Sunrise, Florida.

Name
MEDNAX
CEO
Mark S. Ordan
Headquarters Sunrise, fl
USA
Website
Sector
Health Care
Industry
Health Care Providers & Services
IPO
09/20/1995
Employees 4,280

Ticker symbols

Exchange Symbol
NYSE
MD
Frankfurt
PDC.F
SIX
PDC.SW
🍪

Parqet  uses cookies. Learn more